BIOTECHNOLOGY VALUE FUND L P - 30 Jun 2025 SCHEDULE 13G/A Report for Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share (UNCY)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
UNCY
Shares outstanding
14,185,355 shares
Disclosed Ownership
1,417,117 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:05:01 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 5.7% 777,308 0 777,308 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 5.7% 777,308 0 777,308 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 4.4% 591,650 0 591,650 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 4.4% 591,650 0 591,650 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.3% 35,480 0 35,480 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.3% 35,480 0 35,480 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.7% 1,368,958 0 1,368,958 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 10% 1,417,117 0 1,417,117 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 10% 1,417,117 0 1,417,117 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 10% 1,417,117 0 1,417,117 /s/ Mark N. Lampert Mark N. Lampert